Top Banner
PERICARDIAL EFFUSION AND CARDIAC TAMPONADE Sunitha Daniel
18

Sunitha Daniel. Brief Overview Causes Clinical Presentation Investigations Management Update.

Dec 16, 2015

Download

Documents

Karen Kennedy
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

PERICARDIAL EFFUSION AND

CARDIAC TAMPONADE

Sunitha Daniel

Page 2: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

OUTLINE Brief Overview Causes Clinical Presentation Investigations Management Update

Page 3: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

OVERVIEW Abnormal amount

of and/or an abnormal character to fluid in the pericardial space.

Normal fluid 15-50ml

Among malignancies lung-highest prevalance(37%)

Page 4: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

CAUSESPrimary Acute

inflammatory pericarditis (infectious-viral(HIV),bacterial,fungal autoimmune)

Previously unknown neoplasia

Idiopathic

Secondary Acute MI Cardiac surgery Trauma Metastasis Chest irradiation End-stage renal failure Hypothyroidism Autoimmune diseases Pulm HTN Chylopericardium Drugs : procainamide,

hydralazine, INH, minoxidil, phenytoin, anticoagulants

Page 5: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

Corey et al Colombo et al Sagristà-Sauleda et al

Corey et al

Effusion > 5 mm > 10 mm > 10 mm Not reported

n 57 25 322 106

Tamponade (%) Not reported 44 37 Not reported

Idiopathic (%) 7 32 20 25

Chronic idiopathic effusion (%)

? ? 9 ?

Neoplastic (%) 23 36 13 37

Uremia (%) 12 20 6 4

Iatrogenic (%) 0 0 16 0

Post-acute myocardial infarction (%)

0 8 8 0

Viral (%) 14 0 0 7

Collagen vascular disease (%)

12 0 5 5

Tuberculosis (%) 0 0 2 2

Other (%) 9 4 21 20

Page 6: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

CLINICAL FEATURESSymptoms Chest pain. Syncope Palpitations Cough Dyspneoa Hoarseness

Signs Beck triad Pulsus paradoxus Pericardial friction rub Tachycardia Hepatojugular reflux Tachypnea Decreased breath

sounds Ewart sign Weakened peripheral

pulses, edema, and cyanosis.

Page 7: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

ECGStage I - Diffuse ST-

segment elevation and PR-segment depression

Stage II - Normalization of the ST and PR segments

Stage III - Widespread T-wave inversions:

Stage IV - Normalization of the T waves

Page 8: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

CXR Enlarged cardiac

silhouette (water-bottle heart)

Pericardial fat stripe.

Pleural effusion(1/3)

Page 9: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

ECHOCARDIOGRAPHY Echo-free space

between the visceral and parietal pericardium

Small effusions < 10 mm and are generally seen posteriorly

Moderate 10-20 mm and are circumferential.

Large :>20 mm

Page 10: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

CT &MRI loculated

pericardial effusions.

CT detects 50ml fluid

MRI 30ml fluid. MRI for

hemorrhagic and non hemaorrhagic

Page 11: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

TREATMENT Based on etiology Medical Surgical

Page 12: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

MEDICAL Aspirin/NSAIDs – viral/idiopathic Colchicine –relapsing pericarditis Steroids- systemic

inflammation/pregnancy/autoimmune Antibiotics Chemotherapy

Page 13: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

MANAGEMENT STRATEGY

Page 14: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

INDICATIONS FOR PERICARDIAL DRAINAGE PROCEDURES Diagnostic or therapeutic purposes Not routinely for diagnosis-poor yield. Strong suspicion of purulent or

tuberculous pericarditis. Malignancy Asymptomatic patients with massive

idiopathic chronic pericardial effusion

Page 15: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

PROCEDURES OF PERICARDIAL DRAINAGE

Pericardiocentesis: idiopathic/viral Indwelling pericardial catheter:

neoplastic Percutaneous ballon pericardiotomy Subxiphoid pericardiotomy: purulent Pleuropericardial window Partial pericardiectomy Wide anterior pericardiectomy

Page 16: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

NEOPLASTIC PERICARDIAL INVOLVEMENT relapses in as many as 40%-50% of

patients terminal patients-pericardiocentesis

alone patients with a longer expected survival-

Indwelling pericardial catheters( 75% success rate)

Balloon pericardiotomy

Page 17: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

MANAGEMENT STRATEGY

Page 18: Sunitha Daniel.  Brief Overview  Causes  Clinical Presentation  Investigations  Management Update.

REFERENCES Diagnosis and management of

pericardial effusion World J Cardiol. 2011 May 26; 3(5): 135–143.

Management of pericardial effusion Eur Heart J first published online November 2, 2012 doi:10.1093/eurheartj/ehs372

http://emedicine.medscape.com/article/157325-overview